THC BioMed Receives Health Canada Approval For Production in 3 additional Strata lots

VANCOUVER, July 9, 2019 /PRNewswire/ – THC BioMed Intl Ltd. (“THC BioMed”, or the “Company”) (THC.CN) is pleased to announce that it has received Health Canada’s approval to proceed with production in 3 additional strata lots at its flagship location on Acland Road in Kelowna B.C. “The granting of the 3 additional Strata lots will actually double our approved growing space and makes a significant change for THC BioMed. This is a major milestone,” said John Miller, President and CEO of THC BioMed.